[go: up one dir, main page]

WO1992000323A3 - pp150 DU CYTOMEGALOVIRUS HUMAIN - Google Patents

pp150 DU CYTOMEGALOVIRUS HUMAIN Download PDF

Info

Publication number
WO1992000323A3
WO1992000323A3 PCT/GB1991/001064 GB9101064W WO9200323A3 WO 1992000323 A3 WO1992000323 A3 WO 1992000323A3 GB 9101064 W GB9101064 W GB 9101064W WO 9200323 A3 WO9200323 A3 WO 9200323A3
Authority
WO
WIPO (PCT)
Prior art keywords
hcmv
human cytomegalovirus
antigen
protein
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1991/001064
Other languages
English (en)
Other versions
WO1992000323A2 (fr
Inventor
Brian Colin Rodgers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of WO1992000323A2 publication Critical patent/WO1992000323A2/fr
Publication of WO1992000323A3 publication Critical patent/WO1992000323A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Y@invention se rapporte à un procédé destiné à produire une protéine de cytomégalovirus humain (HCMV) dans des cellules d'insectes et à des vaccins et des analyses immunologiques contenant la protéine obtenue au moyen de ce procédé.
PCT/GB1991/001064 1990-07-02 1991-07-01 pp150 DU CYTOMEGALOVIRUS HUMAIN Ceased WO1992000323A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909014652A GB9014652D0 (en) 1990-07-02 1990-07-02 Antigen
GB9014652.3 1990-07-02

Publications (2)

Publication Number Publication Date
WO1992000323A2 WO1992000323A2 (fr) 1992-01-09
WO1992000323A3 true WO1992000323A3 (fr) 1992-02-06

Family

ID=10678538

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1991/001064 Ceased WO1992000323A2 (fr) 1990-07-02 1991-07-01 pp150 DU CYTOMEGALOVIRUS HUMAIN

Country Status (4)

Country Link
AU (1) AU8204991A (fr)
GB (1) GB9014652D0 (fr)
IE (1) IE912291A1 (fr)
WO (1) WO1992000323A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040165A1 (fr) 1996-04-23 1997-10-30 The Wistar Institute Of Anatomy And Biology Nouveaux produits de construction d'adn de cytomegalovirus humain, et leurs utilisations
KR100624517B1 (ko) * 1996-07-12 2006-09-18 악조 노벨 엔.브이. 인간 사이토메갈로바이러스 검출용 펩티드 시약
IT1290804B1 (it) * 1996-08-16 1998-12-11 Abbott Lab Saggio western blot perfezionato per l'individuazione di anticorpi specifici contro il virus hcmv

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252531A1 (fr) * 1986-06-12 1988-01-13 BEHRINGWERKE Aktiengesellschaft Phosphoprotéine structurale (pp 150) de cytomégalovirus humain, sa préparation et son utilisation
EP0340359A1 (fr) * 1988-05-06 1989-11-08 The Wellcome Foundation Limited Vecteurs de transfert de Baculovirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0252531A1 (fr) * 1986-06-12 1988-01-13 BEHRINGWERKE Aktiengesellschaft Phosphoprotéine structurale (pp 150) de cytomégalovirus humain, sa préparation et son utilisation
EP0340359A1 (fr) * 1988-05-06 1989-11-08 The Wellcome Foundation Limited Vecteurs de transfert de Baculovirus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Virology, volume 61, no. 5, May 1987, American Society for Microbiology, G. Jahn et al.: "Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus", pages 1358-1367, see the whole article (cited in the application) *

Also Published As

Publication number Publication date
AU8204991A (en) 1992-01-23
WO1992000323A2 (fr) 1992-01-09
GB9014652D0 (en) 1990-08-22
IE912291A1 (en) 1992-01-15

Similar Documents

Publication Publication Date Title
AU5999490A (en) Chimeric antibodies directed against a human glycoprotein antigen
AU1085488A (en) Monoclonal antibodies to a pan-malarial antigen
AU5267190A (en) Modified antibodies
AU2843889A (en) Antigen antibody conjugate
AU652970B2 (en) Squamous cell carcinoma-like immunoreactive antigen from human female urine
CS9100012A2 (en) Biomass for virus/virus antigen production
EP0683675A4 (fr) Anticorps monoclonaux humains contre le cytomegalovirus.
AU6036690A (en) Human monoclonal antibodies to hiv-1mn gp 120
AU2133292A (en) Hcmv-specific peptides, agents therefor and the use thereof
WO1992000323A3 (fr) pp150 DU CYTOMEGALOVIRUS HUMAIN
AU8944291A (en) Immunoassay for the determination of anti-hiv antibodies in human samples
AU616667B2 (en) Monoclonal antibodies against e7 protein of human type 16 papillomavirus, a process for their preparation, and their use
AU4212789A (en) Cloned nephritis antigen
AU6873587A (en) Monoclonal antibodies useful in the identification of microorganisms causing peridontal disease
AU2637492A (en) Artificial standard and control sera, processes for the preparation thereof and the use thereof
AU680836B2 (en) Human monoclonal antibodies to human immunodeficiency virus
AU4174789A (en) Hybrid monoclonal antibodies, their production and use
AU3829189A (en) Detecting antigens or antibodies
AU1820692A (en) Novel anti-hiv antibodies
AU6777594A (en) Human monoclonal antibodies to human cytomegalovirus, and methods therefor
AU3432389A (en) Human monoclonal antibodies against rabies virus
AU5873094A (en) Multivalent ab1 antibodies as vaccines
AU5217890A (en) Monoclonal antibodies in vaccine formulations
AU7862291A (en) Modified antibodies
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU NL SE

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA